The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study
Open accessAbstract
AIMS: Estimate the prevalence of cannabis dependence and its contribution to the global burden of disease. METHODS: Systematic reviews of epidemiological data on cannabis dependence (1990-2008) were conducted in line with PRISMA and meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Culling and data extraction followed protocols, with cross-checking and consistency checks. DisMod-MR, the latest version of generic disease modelling system, redesigned as a Bayesian meta-regression tool, imputed prevalence by age, year and sex for 187 countries and 21 regions. The disability weight associated with cannabis dependence was estimated through population surveys and multiplied by prevalence data to calculate the years of life lived with disability (YLDs) and disability-adjusted life years (DALYs). YLDs and DALYs attributed to regular cannabis use as a risk factor for schizophrenia were also estimated. RESULTS: There were an estimated 13.1 million cannabis dependent people globally in 2010 (point prevalence0.19% (95% uncertainty: 0.17-0.21%)). Prevalence peaked between 20-24 yrs, was higher in males (0.23% (0.2-0.27%)) than females (0.14% (0.12-0.16%)) and in high income regions. Cannabis dependence accounted for 2 million DALYs globally (0.08%; 0.05-0.12%) in 2010; a 22% increase in crude DALYs since 1990 largely due to population growth. Countries with statistically higher age-standardised DALY rates included the United States, Canada, Australia, New Zealand and Western European countries such as the United Kingdom; those with lower DALY rates were from Sub-Saharan Africa-West and Latin America. Regular cannabis use as a risk factor for schizophrenia accounted for an estimated 7,000 DALYs globally. CONCLUSION: Cannabis dependence is a disorder primarily experienced by young adults, especially in higher income countries. It has not been shown to increase mortality as opioid and other forms of illicit drug dependence do. Our estimates suggest that cannabis use as a risk factor for schizophrenia is not a major contributor to population-level disease burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders
Knapp, W. P., Soares, B., Farrell, M., & Silva de Lima, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003023.pub2 · Cited by 178
RetractedPsychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings
Denis, C., Lavie, E., Fatseas, M., & Auriacombe, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005336.pub2 · Cited by 128
RetractedPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61602-x · Cited by 21,320
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Self-citationDiagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citation(1996) · Cited by 6,884
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
No health without mental health
Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61238-0 · Cited by 3,753
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
A Systematic Review of the Prevalence of Schizophrenia
Saha, S., Chant, D., Welham, J., & McGrath, J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020141 · Cited by 2,168
Self-citationSalomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A., Begum, N., Shah, R., Karyana, M., Kosen, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61680-8 · Cited by 1,322
Self-citationExtent of illicit drug use and dependence, and their contribution to the global burden of disease
Degenhardt, L., & Hall, W. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61138-0 · Cited by 1,303
Self-citationAdverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Self-citationCausal association between cannabis and psychosis: examination of the evidence
Arseneault, L., Cannon, M., Witton, J., & Murray, R. M. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 913
Cannabis use disorders in the USA: prevalence, correlates and co-morbidity
STINSON, F. S., RUAN, W. J., PICKERING, R., & GRANT, B. F. (2006) · Psychological Medicine · doi:10.1017/s0033291706008361 · Cited by 422
A generic model for the assessment of disease epidemiology: the computational basis of DisMod II
Barendregt, J. J., van Oortmarssen, G. J., Vos, T., & Murray, C. J. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-4 · Cited by 402
Self-citationEffects of cannabis use on outcomes of psychotic disorders: systematic review
Zammit, S., Moore, T. H. M., Lingford-Hughes, A., Barnes, T. R. E., Jones, P. B., Burke, M., & Lewis, G. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046375 · Cited by 275
Testing hypotheses about the relationship between cannabis use and psychosis
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270
Self-citationNeurobiology of marijuana abuse
Abood, M. E., & Martin, B. R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90064-d · Cited by 250
Gene-Environment Interplay Between Cannabis and Psychosis
Henquet, C., Di Forti, M., Morrison, P., Kuepper, R., & Murray, R. M. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn108 · Cited by 247
Cannabis Use and the Course of Schizophrenia: 10-Year Follow-Up After First Hospitalization
Foti, D. J., Kotov, R., Guey, L. T., & Bromet, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09020189 · Cited by 223
Cannabis use and misuse prevalence among people with psychosis
Green, B., Young, R., & Kavanagh, D. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.4.306 · Cited by 215
Cannabis, Vulnerability, and the Onset of Schizophrenia: An Epidemiological Perspective
Hambrecht, M., & Häfner, H. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00736.x · Cited by 205
CALABRIA, B., DEGENHARDT, L., HALL, W., & LYNSKEY, M. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00149.x · Cited by 185
Self-citationIs Cannabis Use a Contributory Cause of Psychosis?
Degenhardt, L. J., & Hall, W. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100903 · Cited by 173
Self-citationPrevalence and correlates of cannabis use in developed and developing countries
Hall, W., & Degenhardt, L. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32812144cc · Cited by 166
Self-citationDegenhardt, L. J., Bucello, C., Calabria, B., Nelson, P. K., Roberts, A., Hall, W., Lynskey, M. T., Wiessing, L. G., Mora, M. E. M., Clark, N., et al. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.032 · Cited by 136
Self-citationCalabria, B., Degenhardt, L. J., Briegleb, C., Vos, T., Hall, W., Lynskey, M. T., Callaghan, B. L., Rana, U., & McLaren, J. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.03.019 · Cited by 119
Self-citationHickman, M., Vickerman, P. T., Macleod, J., Kirkbride, J. B., & Jones, P. B. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01710.x · Cited by 116
Hall, W. (1998) · Drug and Alcohol Review · doi:10.1080/09595239800187271 · Cited by 102
Self-citationNew disability weights for the global burden of disease
Salomon, J. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.10.084301 · Cited by 62
What are the Policy Implications of the Evidence on Cannabis and Psychosis?
Hall, W., & Degenhardt, L. J. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100904 · Cited by 54
Self-citationChanging incidence of psychotic disorders among the young in Zurich
Ajdacic‐Gross, V., Lauber, C., Warnke, I., Haker, H., Murray, R. M., & Wulf Rössler, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.001 · Cited by 53
Should Burden of Disease Estimates Include Cannabis Use as a Risk Factor for Psychosis?
Degenhardt, L. J., Hall, W., Lynskey, M. T., McGrath, J. J., McLaren, J., Calabria, B., Whiteford, H., & Vos, T. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000133 · Cited by 52
Self-citationChemistry and pharmacology of cannabis
Seth, R., & Sinha, S. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7136-5_3 · Cited by 27
Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study
Ferrari, A. J., Saha, S., McGrath, J. J., Norman, R., Baxter, A. J., Vos, T., & Whiteford, H. A. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-16 · Cited by 1 · cited 2×
“The percent of time spent in acute psychosis was 63% (38%-82%) based on a meta-analysis of 6 studies covering 5 GBD world regions[49].”
BackgroundSelf-citation
Cited by
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Self-citationWhiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116820 · Cited by 1,175
Self-citationErskine, H. E., Moffitt, T. E., Copeland, W. E., Costello, E. J., Ferrari, A. J., Patton, G., Degenhardt, L., Vos, T., Whiteford, H. A., & Scott, J. G. (2015) · Psychological Medicine · doi:10.1017/s0033291714002888 · Cited by 688
Self-citationThe increasing global health priority of substance use in young people
Degenhardt, L., Stockings, E., Patton, G., Hall, W. D., & Lynskey, M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00508-8 · Cited by 601
Self-citationLower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 433
Self-citation
Metadata
- Authors
- Degenhardt, L., Ferrari, A. J., Calabria, B., Hall, W. D., Norman, R. E., McGrath, J., Flaxman, A. D., Engell, R. E., Freedman, G. D., Whiteford, H. A., & Vos, T.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-24
- Volume
- 8
- Issue
- 10
- Pages
- e76635
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1757260719
- Cited by
- 298
- References
- 42
- FWCI
- 15.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.